136 related articles for article (PubMed ID: 8835109)
21. Marked susceptibility of South African Helicobacter pylori strains to ciprofloxacin and amoxicillin: clinical implications.
Tanih NF; Okeleye BI; Naidoo N; Clarke AM; Mkwetshana N; Green E; Ndip LM; Ndip RN
S Afr Med J; 2010 Jan; 100(1):49-52. PubMed ID: 20429489
[TBL] [Abstract][Full Text] [Related]
22. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
Hu CT; Wu CC; Lin CY; Cheng CC; Su SC; Tseng YH; Lin NT
J Gastroenterol Hepatol; 2007 May; 22(5):720-3. PubMed ID: 17444862
[TBL] [Abstract][Full Text] [Related]
23. Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains.
van Zwet AA; Thijs JC; de Graaf B
Antimicrob Agents Chemother; 1995 Jan; 39(1):250-2. PubMed ID: 7695317
[TBL] [Abstract][Full Text] [Related]
24. Amoxicillin for the treatment of Helicobacter pylori infection.
Hirschl AM; Rotter ML
J Gastroenterol; 1996 Nov; 31 Suppl 9():44-7. PubMed ID: 8959518
[TBL] [Abstract][Full Text] [Related]
25. [Antibiotic-resistant H. pylori strains in the last ten years in Japan].
Murakami K; Kimoto M
Nihon Rinsho; 1999 Jan; 57(1):81-6. PubMed ID: 10036940
[TBL] [Abstract][Full Text] [Related]
26. Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
Fennerty MB
Am J Gastroenterol; 1998 Jan; 93(1):2-3. PubMed ID: 9448162
[No Abstract] [Full Text] [Related]
27. Sucralfate affects the susceptibility of Helicobacter pylori to antimicrobial agents.
Slomiany BL; Piotrowski J; Majka J; Slomiany A
Scand J Gastroenterol Suppl; 1995; 210():82-4. PubMed ID: 8578215
[TBL] [Abstract][Full Text] [Related]
28. Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance.
Veldhuyzen van Zanten S; Hunt RH; Cockeram A; Schep G; Malatjalian D; Sidorov J; Matisko A; Jewell D
Am J Gastroenterol; 1998 Jan; 93(1):5-10. PubMed ID: 9448164
[TBL] [Abstract][Full Text] [Related]
29. In vitro activities of a new ketolide, ABT-773, alone and in combination with amoxicillin, metronidazole, or tetracycline against Helicobacter pylori.
Pendland SL; Prause JL; Neuhauser MM; Boyea N; Hackleman JM; Danziger LH
Antimicrob Agents Chemother; 2000 Sep; 44(9):2518-20. PubMed ID: 10952605
[TBL] [Abstract][Full Text] [Related]
30. [Problems following antibiotic therapy for eradication of Helicobacter pylori].
Sato R; Kubota T; Murakami K; Fujioka T
Nihon Naika Gakkai Zasshi; 1998 May; 87(5):881-5. PubMed ID: 9648440
[No Abstract] [Full Text] [Related]
31. In vitro selection of resistant Helicobacter pylori.
Haas CE; Nix DE; Schentag JJ
Antimicrob Agents Chemother; 1990 Sep; 34(9):1637-41. PubMed ID: 2285275
[TBL] [Abstract][Full Text] [Related]
32. Antibacterial action of the urease inhibitor acetohydroxamic acid on Helicobacter pylori.
Phillips K; Munster DJ; Allardyce RA; Bagshaw PF
J Clin Pathol; 1993 Apr; 46(4):372-3. PubMed ID: 8496397
[TBL] [Abstract][Full Text] [Related]
33. Resistance of helicobacter pylori to metronidazole, tetracycline and amoxycillin.
Wu H; Shi XD; Wang HT; Liu JX
J Antimicrob Chemother; 2000 Jul; 46(1):121-3. PubMed ID: 10882700
[TBL] [Abstract][Full Text] [Related]
34. Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan.
Cheng A; Sheng WH; Liou JM; Wang HP; Wu MS; Lin JT; Chang SC
J Microbiol Immunol Infect; 2015 Feb; 48(1):72-9. PubMed ID: 23036269
[TBL] [Abstract][Full Text] [Related]
35. High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children.
Agudo S; Alarcón T; Cibrelus L; Urruzuno P; Martínez MJ; López-Brea M
Rev Esp Quimioter; 2009 Jun; 22(2):88-92. PubMed ID: 19544100
[TBL] [Abstract][Full Text] [Related]
36. The action of bismuth against Helicobacter pylori mimics but is not caused by intracellular iron deprivation.
Bland MV; Ismail S; Heinemann JA; Keenan JI
Antimicrob Agents Chemother; 2004 Jun; 48(6):1983-8. PubMed ID: 15155188
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic susceptibility patterns of Helicobacter pylori strains isolated from northeastern Mexico.
Garza-González E; Pérez-Pérez GI; Alanís-Aguilar O; Tijerina-Menchaca R; Maldonado-Garza HJ; Bosques-Padilla FJ
J Chemother; 2002 Aug; 14(4):342-5. PubMed ID: 12420850
[TBL] [Abstract][Full Text] [Related]
38. Resistance of Helicobacter pylori to tetracycline, amoxicillin, clarithromycin and metronidazole in Israeli children and adults.
Peretz A; Paritsky M; Nasser O; Brodsky D; Glyatman T; Segal S; On A
J Antibiot (Tokyo); 2014 Aug; 67(8):555-7. PubMed ID: 24781955
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of a novel antimicrobial agent, TG44, for treatment of Helicobacter pylori infection.
Kamoda O; Anzai K; Mizoguchi J; Shiojiri M; Yanagi T; Nishino T; Kamiya S
Antimicrob Agents Chemother; 2006 Sep; 50(9):3062-9. PubMed ID: 16940102
[TBL] [Abstract][Full Text] [Related]
40. High Helicobacter pylori resistance to metronidazole and clarithromycin in Brazilian children and adolescents.
Ogata SK; Godoy AP; da Silva Patricio FR; Kawakami E
J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):645-8. PubMed ID: 23403439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
